Skip to main content
Erschienen in: Pituitary 4/2009

01.12.2009

Effects of 5 years of growth hormone (GH) replacement therapy on cardiac parameters and physical performance in adults with GH deficiency

verfasst von: Maria Claudia Peixoto Cenci, Débora Vieira Soares, Luciana Diniz Carneiro Spina, Rosane Resende de Lima Oliveira Brasil, Priscila Marise Lobo, Vera Aleta Mansur, Jaime Gold, Eduardo Michmacher, Mario Vaisman, Flávia Lúcia Conceição

Erschienen in: Pituitary | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to evaluate the effects of 5 years of GH substitution on cardiac structure and function, physical work capacity and blood pressure levels in adults with GH deficiency (GHD). Fourteen patients were clinically assessed every 3 months for 5 years. Transthoracic echocardiography and exercise test were performed at baseline, 24, 48 and 60 months. Blood pressure (BP) was measured by means of ambulatory monitoring of blood pressure at baseline, 6, 12, 24 and 60 months. Left ventricular mass and its index increased progressively during the 5 years of GH substitution (P = 0.008 and 0.007, respectively). There were no significant changes in all others cardiac parameters evaluated. It was observed a significant improve in functional capacity (P < 0.001) and maximal oxygen uptake (P = 0.006) during the treatment. Diurnal systolic BP increased by 15 mmHg (P = 0.024) and diurnal diastolic BP by 4.5 mmHg (P = 0.037). There was no change in dirnal systolic pressure load but a considerable but non-statistically significant reduction in diurnal diastolic pressure load was observed during the study. During the night diastolic BP increased by 4 mmHg (P = 0.012) despite a substantial but non-statistically significant reduction in diastolic pressure load. We observed an increase in the proportion of persons with a non-physiological nocturnal fall (non-dippers) throughout the study (from 36.4% at baseline to 54.6% after 60 months of therapy). We concluded that 5 years of GH replacement promoted positive effects on exercise capacity and maximum oxygen uptake in spite of a modest increase in BP levels and left ventricular mass. Continuous monitoring is mandatory to arrive at further conclusions concerning the effects of GH substitution in adults on cardiovascular parameters with respect to possible unfavorable long term effects.
Literatur
1.
Zurück zum Zitat Beshyah SA, Johnston DG (1995) Cardiovascular disease and risk factors in adults with hypopituitarism. Horumon To Rinsho 50:1–15 Beshyah SA, Johnston DG (1995) Cardiovascular disease and risk factors in adults with hypopituitarism. Horumon To Rinsho 50:1–15
2.
Zurück zum Zitat Cuneo RC, Salomon F, Magauley GA, Sönksen PH (1992) The growth hormone deficiency syndrome in adults. Horumon To Rinsho 37:387–397 Cuneo RC, Salomon F, Magauley GA, Sönksen PH (1992) The growth hormone deficiency syndrome in adults. Horumon To Rinsho 37:387–397
4.
Zurück zum Zitat Rosén T, Edén S, Larson G, Wilhelmsen L, Bengtsson B-Å (1993) Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 129:195–200 Rosén T, Edén S, Larson G, Wilhelmsen L, Bengtsson B-Å (1993) Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 129:195–200
5.
Zurück zum Zitat Markussis V, Beshyam AS, Fisher C, Sharp P, Nicolaides NA, Johnson DG (1992) Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 340:1188–1192. doi:10.1016/0140-6736(92)92892-J CrossRefPubMed Markussis V, Beshyam AS, Fisher C, Sharp P, Nicolaides NA, Johnson DG (1992) Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 340:1188–1192. doi:10.​1016/​0140-6736(92)92892-J CrossRefPubMed
7.
Zurück zum Zitat Johansson J-O, Landin K, Tengborn L, Rosén T, Bengtsson B-Å (1994) High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioscler Thromb 14:434–437PubMed Johansson J-O, Landin K, Tengborn L, Rosén T, Bengtsson B-Å (1994) High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioscler Thromb 14:434–437PubMed
8.
Zurück zum Zitat Cuneo RC, Salomon F, Wiles CM, Hesp R, Sönksen PH (1991) Growth hormone treatment in growth hormone deficient adults. II. Effects on exercise performance. J Appl Physiol 70:695–700PubMed Cuneo RC, Salomon F, Wiles CM, Hesp R, Sönksen PH (1991) Growth hormone treatment in growth hormone deficient adults. II. Effects on exercise performance. J Appl Physiol 70:695–700PubMed
9.
Zurück zum Zitat Colao A, di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M, Lombardi G (2001) Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab 86:1874–1881. doi:10.1210/jc.86.5.1874 CrossRefPubMed Colao A, di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M, Lombardi G (2001) Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab 86:1874–1881. doi:10.​1210/​jc.​86.​5.​1874 CrossRefPubMed
10.
Zurück zum Zitat Bülow B, Hagmar L, Mikoczy Z, Nordstrom CH, Erfurth EM (1997) Increased cerebrovascular mortality in patients with hypopituitarism. Horumon To Rinsho 46:75–81 Bülow B, Hagmar L, Mikoczy Z, Nordstrom CH, Erfurth EM (1997) Increased cerebrovascular mortality in patients with hypopituitarism. Horumon To Rinsho 46:75–81
12.
Zurück zum Zitat Colao A, di Somma C, Cuocolo A, Filippella M, Rota F, Acampa W, Savastano S, Salvatore M, Lombardi G (2004) The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study. J Clin Endocrinol Metab 89:5998–6004. doi:10.1210/jc.2004-1042 CrossRefPubMed Colao A, di Somma C, Cuocolo A, Filippella M, Rota F, Acampa W, Savastano S, Salvatore M, Lombardi G (2004) The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study. J Clin Endocrinol Metab 89:5998–6004. doi:10.​1210/​jc.​2004-1042 CrossRefPubMed
14.
Zurück zum Zitat Amato G, Carella C, Fazio S et al (1993) Body composition, bone metabolism, heart structure and function in growth hormone deficient adults before and after growth hormone replacement therapy at low doses. J Clin Endocrinol Metab 77:1671–1676. doi:10.1210/jc.77.6.1671 CrossRefPubMed Amato G, Carella C, Fazio S et al (1993) Body composition, bone metabolism, heart structure and function in growth hormone deficient adults before and after growth hormone replacement therapy at low doses. J Clin Endocrinol Metab 77:1671–1676. doi:10.​1210/​jc.​77.​6.​1671 CrossRefPubMed
16.
Zurück zum Zitat Colao A, di Somma C, Pivonello R, Cuocolo A, Spinelli L, Tedesco N, Bonaduce D, Salvatore M, Lombardi G (2002) The cardiovascular risk factors of adult GH deficiency (GHD) improved GH replacement and worsened in untreated GHD: a 12-month prospective study. J Clin Endocrinol Metab 87:1088–1093. doi:10.1210/jc.87.3.1088 CrossRefPubMed Colao A, di Somma C, Pivonello R, Cuocolo A, Spinelli L, Tedesco N, Bonaduce D, Salvatore M, Lombardi G (2002) The cardiovascular risk factors of adult GH deficiency (GHD) improved GH replacement and worsened in untreated GHD: a 12-month prospective study. J Clin Endocrinol Metab 87:1088–1093. doi:10.​1210/​jc.​87.​3.​1088 CrossRefPubMed
17.
Zurück zum Zitat Brasil RR, Soares DV, Spina LD, Lobo PM, da Silva EM, Mansur VA, Pinheiro MF, Conceição FL, Vaisman M (2007) Association of insulin resistance and nocturnal fall of blood pressure in GH-deficient adults during GH replacement. J Endocrinol Invest 30:306–312PubMed Brasil RR, Soares DV, Spina LD, Lobo PM, da Silva EM, Mansur VA, Pinheiro MF, Conceição FL, Vaisman M (2007) Association of insulin resistance and nocturnal fall of blood pressure in GH-deficient adults during GH replacement. J Endocrinol Invest 30:306–312PubMed
18.
Zurück zum Zitat Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation in M-mode echocardigraphy of a survey of echocardiographic measurements. Circulation 58:1072–1083PubMed Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation in M-mode echocardigraphy of a survey of echocardiographic measurements. Circulation 58:1072–1083PubMed
19.
21.
Zurück zum Zitat Kannel WB (1992) Left ventricular hypertrophy as a risk factor in arterial hypertension. Eur Heart J 13(Suppl D):82–88PubMed Kannel WB (1992) Left ventricular hypertrophy as a risk factor in arterial hypertension. Eur Heart J 13(Suppl D):82–88PubMed
23.
Zurück zum Zitat Nass R, Huber R, Volken K, Muller O, Schopohl J, Strasburger C (1995) Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J Clin Endocrinol Metab 80:552–557. doi:10.1210/jc.80.2.552 CrossRefPubMed Nass R, Huber R, Volken K, Muller O, Schopohl J, Strasburger C (1995) Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J Clin Endocrinol Metab 80:552–557. doi:10.​1210/​jc.​80.​2.​552 CrossRefPubMed
24.
Zurück zum Zitat Cuneo RC, Salomon F, Wimshurst P, Byrne C, Wiles CM, Hesp R, Sonken PH (1991) Cardiovascular effects of growth hormone treatment in growth-hormone deficient adults: stimulation of the renin-aldosterone system. Clin Sci 81:587–592PubMed Cuneo RC, Salomon F, Wimshurst P, Byrne C, Wiles CM, Hesp R, Sonken PH (1991) Cardiovascular effects of growth hormone treatment in growth-hormone deficient adults: stimulation of the renin-aldosterone system. Clin Sci 81:587–592PubMed
25.
Zurück zum Zitat Caidahl K, Edén S, Bengtsson B-A (1994) Cardiovascular and renal effects of growth hormone. Clin Endocrinol (Oxf) 40:393–400 Caidahl K, Edén S, Bengtsson B-A (1994) Cardiovascular and renal effects of growth hormone. Clin Endocrinol (Oxf) 40:393–400
26.
Zurück zum Zitat Follin C, Thilén U, Ahrén B, Erfurth EM (2006) Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. J Clin Entocrinol Metab 91:1872–1875CrossRef Follin C, Thilén U, Ahrén B, Erfurth EM (2006) Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. J Clin Entocrinol Metab 91:1872–1875CrossRef
27.
Zurück zum Zitat Minczykowski A, Gryczynska M, Ziemnicka K, Czepczynski R, Sowinski J, Wysocki H (2005) The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency. Growth Horm IGF Res 15:156–164. doi:10.1016/j.ghir.2005.01.001 CrossRefPubMed Minczykowski A, Gryczynska M, Ziemnicka K, Czepczynski R, Sowinski J, Wysocki H (2005) The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency. Growth Horm IGF Res 15:156–164. doi:10.​1016/​j.​ghir.​2005.​01.​001 CrossRefPubMed
28.
Zurück zum Zitat Johannsson G, Rosén T, Lindstedt G, Bosaeus I, Bengtsson B-A (1996) Effects of two years of growth hormone treatment on body composition and cardiovascular risk factors in adults with growth hormone deficiency. Endocrinol Metab 3(Suppl. A):3–12 Johannsson G, Rosén T, Lindstedt G, Bosaeus I, Bengtsson B-A (1996) Effects of two years of growth hormone treatment on body composition and cardiovascular risk factors in adults with growth hormone deficiency. Endocrinol Metab 3(Suppl. A):3–12
29.
Zurück zum Zitat Thuesen L, Jørgensen JOL, Müller JR, Kristensen Bø, Skakkebæk NE, Vahl N, Cristiansen JS (1994) Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults. Clin Endocrinol (Oxf) 41:615–620. doi:10.1111/j.1365-2265.1994.tb01827.x CrossRef Thuesen L, Jørgensen JOL, Müller JR, Kristensen Bø, Skakkebæk NE, Vahl N, Cristiansen JS (1994) Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults. Clin Endocrinol (Oxf) 41:615–620. doi:10.​1111/​j.​1365-2265.​1994.​tb01827.​x CrossRef
32.
Zurück zum Zitat Cittadini A, Cuocolo A, Merola B, Fazio S, Sabatini D, Nicolai E, Colao A, Longobardi S, Lombarti G, Sacca L (1994) Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. Am J Physiol 267:E219–E225PubMed Cittadini A, Cuocolo A, Merola B, Fazio S, Sabatini D, Nicolai E, Colao A, Longobardi S, Lombarti G, Sacca L (1994) Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. Am J Physiol 267:E219–E225PubMed
33.
Zurück zum Zitat Jorgensen JOL, Vahl N, Nyholm B, Juul A, Muller J, Moller N, Schmitz O, Skakkeboek NE, Christiansen JS (1996) Substrate metabolism and insulin sensivity following long-term growth hormone (GH) replacement therapy in GH-deficient adults. Endocrinol Metab 3:281–286 Jorgensen JOL, Vahl N, Nyholm B, Juul A, Muller J, Moller N, Schmitz O, Skakkeboek NE, Christiansen JS (1996) Substrate metabolism and insulin sensivity following long-term growth hormone (GH) replacement therapy in GH-deficient adults. Endocrinol Metab 3:281–286
34.
Zurück zum Zitat Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR (1992) Growth hormone treatment of adults with growth hormone deficiency: results of a 13 month placebo controlled cross-over study. Clin Endocrinol (Oxf) 36:45–52. doi:10.1111/j.1365-2265.1992.tb02901.x CrossRef Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR (1992) Growth hormone treatment of adults with growth hormone deficiency: results of a 13 month placebo controlled cross-over study. Clin Endocrinol (Oxf) 36:45–52. doi:10.​1111/​j.​1365-2265.​1992.​tb02901.​x CrossRef
35.
Zurück zum Zitat Jørgensen JOL, Pedersen SA, Thuesen L, Jørgensen J, Møller J, Muller J, Skakkebaek NE, Christiansen JS (1991) Long-term growth hormone treatment in growth hormone deficient adults. Acta Endocrinol (Copenh) 125:449–453 Jørgensen JOL, Pedersen SA, Thuesen L, Jørgensen J, Møller J, Muller J, Skakkebaek NE, Christiansen JS (1991) Long-term growth hormone treatment in growth hormone deficient adults. Acta Endocrinol (Copenh) 125:449–453
37.
Zurück zum Zitat Friedman M, Byers SO, Rosenman RH, Li CH, Neuman R (1974) Effect of subacute administration of human growth hormone on various serum lipid and hormone levels of hypercholesterolemic and normocholesterolemic subjects. Metabolism 23:905–912. doi:10.1016/0026-0495(74)90039-0 CrossRefPubMed Friedman M, Byers SO, Rosenman RH, Li CH, Neuman R (1974) Effect of subacute administration of human growth hormone on various serum lipid and hormone levels of hypercholesterolemic and normocholesterolemic subjects. Metabolism 23:905–912. doi:10.​1016/​0026-0495(74)90039-0 CrossRefPubMed
38.
Zurück zum Zitat Wallymahmed ME, Foy P, Shaw D et al (1997) Quality of life, body composition and muscle strenght in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years. Clin Endocrinol (Oxf) 47:439–446. doi:10.1046/j.1365-2265.1997.2801076.x CrossRef Wallymahmed ME, Foy P, Shaw D et al (1997) Quality of life, body composition and muscle strenght in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years. Clin Endocrinol (Oxf) 47:439–446. doi:10.​1046/​j.​1365-2265.​1997.​2801076.​x CrossRef
39.
40.
Zurück zum Zitat Gibbons RJ, Balady GJ, Beasley JW et al (1997) ACC/AHA guidelines for exercise testing. A report of the American college of cardiology/American heart association task force on practice guidelines (Committee on exercise testing). J Am Coll Cardiol 30:260–311. doi:10.1016/S0735-1097(97)00150-2 CrossRefPubMed Gibbons RJ, Balady GJ, Beasley JW et al (1997) ACC/AHA guidelines for exercise testing. A report of the American college of cardiology/American heart association task force on practice guidelines (Committee on exercise testing). J Am Coll Cardiol 30:260–311. doi:10.​1016/​S0735-1097(97)00150-2 CrossRefPubMed
41.
Zurück zum Zitat Boger RH, Skamira C, Bode-Boger SM, Brabant G, von zur Muhlen A, Frolich JC (1996) Nitric oxide may mediate hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. J Clin Endocrinol Invest 98:2706–2713. doi:10.1172/JCI119095 CrossRef Boger RH, Skamira C, Bode-Boger SM, Brabant G, von zur Muhlen A, Frolich JC (1996) Nitric oxide may mediate hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. J Clin Endocrinol Invest 98:2706–2713. doi:10.​1172/​JCI119095 CrossRef
42.
Zurück zum Zitat Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P (2004) Impact of growth-hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab 89:2192–2199. doi:10.1210/jc.2003-030840 CrossRefPubMed Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P (2004) Impact of growth-hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab 89:2192–2199. doi:10.​1210/​jc.​2003-030840 CrossRefPubMed
43.
Zurück zum Zitat Attanasio AF, Bates PC, Ho KKY et al (2002) Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status-3-year results from the HypoCCS database. J Clin Endocrinol Metab 87:1600–1606. doi:10.1210/jc.87.4.1600 CrossRefPubMed Attanasio AF, Bates PC, Ho KKY et al (2002) Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status-3-year results from the HypoCCS database. J Clin Endocrinol Metab 87:1600–1606. doi:10.​1210/​jc.​87.​4.​1600 CrossRefPubMed
44.
Zurück zum Zitat Abs R, Feldt-Rasmunssen U, Mattsson AF, Monson JP, Bengtsson BA, Goth MI, Wilton P, Koltowska-Haggstrom M (2006) Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults–a KIMS database analysis. Eur J Endocrinol 155:79–90. doi:10.1530/eje.1.02179 CrossRefPubMed Abs R, Feldt-Rasmunssen U, Mattsson AF, Monson JP, Bengtsson BA, Goth MI, Wilton P, Koltowska-Haggstrom M (2006) Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults–a KIMS database analysis. Eur J Endocrinol 155:79–90. doi:10.​1530/​eje.​1.​02179 CrossRefPubMed
45.
Zurück zum Zitat Franco C, Gudmundur J, Bengtsson B-A, Svensson J (2006) Baseline characteristics and effects of growth hormone therapy over two years in youngers and elderly adults with adult onset GH deficiency. J Endocrinol Metab 91:4408–4414. doi:10.1210/jc.2006-0887 CrossRef Franco C, Gudmundur J, Bengtsson B-A, Svensson J (2006) Baseline characteristics and effects of growth hormone therapy over two years in youngers and elderly adults with adult onset GH deficiency. J Endocrinol Metab 91:4408–4414. doi:10.​1210/​jc.​2006-0887 CrossRef
46.
Zurück zum Zitat Khoury S, Yarows SA, O’Brien TK, Sowers JR (1992) Ambulatory blood pressure monitoring in a nonacademicsetting. Effects of age and sex. Am J Hypertens 5:616–623PubMed Khoury S, Yarows SA, O’Brien TK, Sowers JR (1992) Ambulatory blood pressure monitoring in a nonacademicsetting. Effects of age and sex. Am J Hypertens 5:616–623PubMed
47.
Zurück zum Zitat Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O’Brien E (2005) Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 46:156–161. doi:10.1161/01.HYP.0000170138.56903.7a CrossRefPubMed Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O’Brien E (2005) Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 46:156–161. doi:10.​1161/​01.​HYP.​0000170138.​56903.​7a CrossRefPubMed
48.
Zurück zum Zitat Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O’Brien E (2003) Office versus ambulatory pressure study investigators. Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. N Engl J Med 348:207–215. doi:10.1056/NEJMoa022273 CrossRef Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O’Brien E (2003) Office versus ambulatory pressure study investigators. Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. N Engl J Med 348:207–215. doi:10.​1056/​NEJMoa022273 CrossRef
Metadaten
Titel
Effects of 5 years of growth hormone (GH) replacement therapy on cardiac parameters and physical performance in adults with GH deficiency
verfasst von
Maria Claudia Peixoto Cenci
Débora Vieira Soares
Luciana Diniz Carneiro Spina
Rosane Resende de Lima Oliveira Brasil
Priscila Marise Lobo
Vera Aleta Mansur
Jaime Gold
Eduardo Michmacher
Mario Vaisman
Flávia Lúcia Conceição
Publikationsdatum
01.12.2009
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 4/2009
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-009-0182-2

Weitere Artikel der Ausgabe 4/2009

Pituitary 4/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.